SWM
NVO

SeaCrest Wealth Management’s Novo Nordisk NVO Stock Holding History

SeaCrest Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,486
Closed -$532K – 629
2026
Q1 		$532K Sell
14,486
-6,217
-30% -$295K 0.06% 309
2025
Q4 		$1.17M Buy
20,703
+15,781
+321% +$807K 0.12% 162
2025
Q3 		$293K Sell
4,922
-1,860
-27% -$109K 0.03% 469
2025
Q2 		$468K Sell
6,782
-4,456
-40% -$303K 0.05% 336
2025
Q1 		$780K Sell
11,238
-278
-2% -$23K 0.09% 223
2024
Q4 		$991K Sell
11,516
-5,947
-34% -$643K 0.1% 185
2024
Q3 		$2.08M Sell
17,463
-73
-0.4% -$9.74K 0.22% 82
2024
Q2 		$2.5M Buy
17,536
+475
+3% +$62.9K 0.28% 54
2024
Q1 		$2.19M Sell
17,061
-106
-0.6% -$12.6K 0.27% 63
2023
Q4 		$1.82M Buy
17,167
+3,083
+22% +$305K 0.22% 90
2023
Q3 		$1.28M Buy
14,084
+3,032
+27% +$267K 0.17% 119
2023
Q2 		$894K Buy
11,052
+1,482
+15% +$121K 0.11% 190
2023
Q1 		$761K Buy
9,570
+2,058
+27% +$146K 0.1% 221
2022
Q4 		$508K Buy
7,512
+1,544
+26% +$90.5K 0.07% 316
2022
Q3 		$297K Buy
5,968
+652
+12% +$34.9K 0.05% 430
2022
Q2 		$296K Sell
5,316
-30
-0.6% -$1.67K 0.04% 468
2022
Q1 		$297K Buy
5,346
+940
+21% +$48.2K 0.03% 508
2021
Q4 		$247K Sell
4,406
-66
-1% -$3.58K 0.03% 577
2021
Q3 		$215K Sell
4,472
-304
-6% -$14.7K 0.03% 606
2021
Q2 		$200K Buy
+4,776
New +$185K 0.02% 650
2020
Q1 		– Sell
-6,996
Closed -$202K – 561
2019
Q4 		$202K Buy
+6,996
New +$194K 0.03% 505
2019
Q2 		– Sell
-7,956
Closed -$208K – 1400
2019
Q1 		$208K Buy
7,956
+230
+3% +$5.65K 0.04% 450
2018
Q4 		$178K Sell
7,726
-138
-2% -$3.07K 0.04% 458
2018
Q3 		$185K Buy
7,864
+1,006
+15% +$24.6K 0.03% 530
2018
Q2 		$158K Buy
6,858
+62
+0.9% +$1.47K 0.03% 575
2018
Q1 		$167K Buy
6,796
+220
+3% +$5.78K 0.03% 541
2017
Q4 		$176K Buy
+6,576
New +$167K 0.03% 541

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

SeaCrest Wealth Management's NVO Position: Q2 2026 in Review

SeaCrest Wealth Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 14,486 shares — an estimated $532K sold.

SeaCrest Wealth Management first reported a position in NVO in Q4 2017 and held it in 27 quarters. The position peaked at $2.5M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • SeaCrest Wealth Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • SeaCrest Wealth Management sold 14,486 Novo Nordisk shares in Q2 2026, an estimated $532K.
  • SeaCrest Wealth Management first reported a position in Novo Nordisk in Q4 2017 and held it in 27 quarters.
  • SeaCrest Wealth Management's Novo Nordisk position peaked at $2.5M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.